Related Experiment Video
Updated: Jan 31, 2026

Ischemia-reperfusion Model of Acute Kidney Injury and Post Injury Fibrosis in Mice
Published on: August 9, 2013
Molybdenum-based nanoclusters act as antioxidants and ameliorate acute kidney injury in mice
Dalong Ni1, Dawei Jiang1,2, Christopher J Kutyreff1
1Departments of Radiology and Medical Physics, University of Wisconsin, Madison, WI, 53705, USA.
Abstract:
Acute kidney injury (AKI) is a common reactive oxygen species (ROS)-related renal disease that causes numerous deaths annually, yet only supportive treatment is currently available in the clinics. Development of antioxidants with high accumulation rates in kidneys is highly desired to help prevent AKI. Here we report molybdenum-based polyoxometalate (POM) nanoclusters with preferential renal uptake as novel nano-antioxidants for kidney protection. These POM nanoclusters, with a readily variable valence state of molybdenum ions, possess the capability to scavenge detrimental ROS. Our results demonstrate that POM nanoclusters can efficiently alleviate clinical symptoms in mice subjected to AKI, as verified by dynamic PET imaging with 68Ga-EDTA, serum tests, kidney tissue staining, and biomarkers detection in the kidneys. The protective effect of POM nanoclusters against AKI in living animals suggests exploring their use for the treatment of AKI patients, as well as patients with other ROS-related diseases.
Insights
Novel molybdenum-based nanoclusters act as potent nano-antioxidants, effectively protecting against acute kidney injury (AKI) by scavenging reactive oxygen species (ROS) in preclinical models.
Area of Science:
- Nanotechnology
- Renal Medicine
- Biochemistry
Background:
- Acute kidney injury (AKI) is a significant cause of mortality, often linked to oxidative stress from reactive oxygen species (ROS).
- Current AKI treatments are primarily supportive, highlighting the need for novel therapeutic agents that target ROS accumulation in the kidneys.
Purpose of the Study:
- To develop and evaluate molybdenum-based polyoxometalate (POM) nanoclusters as targeted nano-antioxidants for the prevention and treatment of AKI.
- To investigate the ROS-scavenging capabilities and renal accumulation of these novel POM nanoclusters.
Main Methods:
- Synthesis of molybdenum-based polyoxometalate (POM) nanoclusters with inherent ROS-scavenging properties.
- Evaluation of renal uptake and biodistribution using dynamic positron emission tomography (PET) imaging with 68Ga-EDTA.
- Assessment of therapeutic efficacy in a mouse model of AKI through serum analysis, kidney tissue staining, and biomarker detection.
Main Results:
- POM nanoclusters demonstrated preferential accumulation in the kidneys.
- The nanoclusters effectively scavenged detrimental reactive oxygen species (ROS).
- Significant alleviation of AKI symptoms was observed in mice treated with POM nanoclusters, confirmed by various physiological and histological assessments.
Conclusions:
- Molybdenum-based POM nanoclusters show promise as effective nano-antioxidants for kidney protection against AKI.
- These findings support further investigation into POM nanoclusters for treating AKI and other ROS-related diseases in clinical settings.
Related Concept Videos
Acute Kidney Injury I: Introduction
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury VI: Nursing Management
Acute Kidney Injury V: Interprofessional Care
Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury IV: Diagnostic Studies and Prevention

